Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.
作者信息
Archer Stephen L, Weir E Kenneth, Wilkins Martin R
机构信息
University of Chicago, IL 60637, USA.
出版信息
Circulation. 2010 May 11;121(18):2045-66. doi: 10.1161/CIRCULATIONAHA.108.847707.
Abstract
摘要
相似文献
1
Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.临床医生的肺动脉高压基础科学：新概念与实验性疗法
Circulation. 2010 May 11;121(18):2045-66. doi: 10.1161/CIRCULATIONAHA.108.847707.
2
Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart.右心室起搏改善实验性肺动脉高压中的右心功能：离体心脏研究
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1752-9. doi: 10.1152/ajpheart.00555.2009. Epub 2009 Sep 4.
3
Task Force 7: Pediatric Cardiology Fellowship Training in Pulmonary Hypertension, Advanced Heart Failure, and Transplantation. SPCTPD/ACC/AAP/AHA.第7工作组：肺动脉高压、晚期心力衰竭及移植领域的儿科心脏病学专科培训。SPCTPD/美国心脏病学会/美国儿科学会/美国心脏协会
Circulation. 2015 Aug 11;132(6):e99-e106. doi: 10.1161/CIR.0000000000000198. Epub 2015 Mar 13.
4
Is p38 MAPK a Dark Force in Right Ventricular Hypertrophy and Failure in Pulmonary Arterial Hypertension?p38丝裂原活化蛋白激酶是肺动脉高压中右心室肥厚和衰竭的“黑暗力量”吗？
Am J Respir Cell Mol Biol. 2017 Nov;57(5):506-508. doi: 10.1165/rcmb.2017-0197ED.
5
Percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension with severe right heart failure.经皮腔内肺动脉成形术治疗伴有严重右心衰竭的慢性血栓栓塞性肺动脉高压
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1437-9. doi: 10.1164/rccm.201312-2254LE.
6
Pulmonary hypertension and right heart failure due to severe hypernatremic dehydration.严重高钠血症性脱水所致的肺动脉高压和右心衰竭。
Perfusion. 2017 Jul;32(5):413-415. doi: 10.1177/0267659117692859. Epub 2017 Feb 1.
7
Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs.犬慢性左心功能不全继发的肺动脉高压
J Small Anim Pract. 2009 Sep;50 Suppl 1:34-43. doi: 10.1111/j.1748-5827.2009.00802.x.
8
Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction.最后，射血分数保留的心力衰竭相关肺动脉高压的研究进展。
Am J Respir Cell Mol Biol. 2017 Apr;56(4):421-422. doi: 10.1165/rcmb.2017-0035ED.
9
Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.射血分数降低的晚期心力衰竭合并毛细血管前和毛细血管后肺动脉高压的管理。
Respir Med. 2017 Oct;131:94-100. doi: 10.1016/j.rmed.2017.08.006. Epub 2017 Aug 9.
10
Cardiovascular modeling in pulmonary arterial hypertension: focus on mechanisms and treatment of right heart failure using the CircAdapt model.肺动脉高压中的心血管建模：使用 CircAdapt 模型关注右心衰竭的机制和治疗。
Am J Cardiol. 2012 Sep 15;110(6 Suppl):39S-48S. doi: 10.1016/j.amjcard.2012.06.015.
引用本文的文献
1
Association of serum copeptin levels with pulmonary complications and heart right ventricular functions in common variable immunodeficiency.普通可变免疫缺陷患者血清 copeptin 水平与肺部并发症及右心室功能的关联
BMC Immunol. 2025 Aug 9;26(1):60. doi: 10.1186/s12865-025-00743-2.
2
Harnessing Mitochondrial Transplantation to Target Vascular Inflammation in Cardiovascular Health.利用线粒体移植靶向心血管健康中的血管炎症。
JACC Basic Transl Sci. 2025 Jul 25;10(8):101331. doi: 10.1016/j.jacbts.2025.101331.
3
Preclinical models of mitochondrial dysfunction: mtDNA and nuclear-encoded regulators in diverse pathologies.线粒体功能障碍的临床前模型：不同病理学中的线粒体DNA和核编码调节因子
Front Aging. 2025 Jun 23;6:1585508. doi: 10.3389/fragi.2025.1585508. eCollection 2025.
4
MTMR7 attenuates the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary hypertension by suppressing ERK/STAT3 signaling.MTMR7通过抑制ERK/STAT3信号传导减弱肺动脉高压中肺动脉平滑肌细胞的增殖和迁移。
Mol Cell Biochem. 2025 Jun;480(6):3799-3812. doi: 10.1007/s11010-025-05217-y. Epub 2025 Feb 7.
5
Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness.Fra-2转基因小鼠的肺血管重塑由2型炎症驱动，并伴有肺血管高反应性。
Am J Physiol Lung Cell Mol Physiol. 2025 Mar 1;328(3):L413-L429. doi: 10.1152/ajplung.00274.2024. Epub 2025 Feb 4.
6
Mitochondrial calcium uniporter complex: An emerging therapeutic target for cardiovascular diseases (Review).线粒体钙单向转运体复合物：心血管疾病中一个新出现的治疗靶点（综述）
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2024.5481. Epub 2025 Jan 3.
7
Skeletal muscle-derived musclin attenuates glycolysis, oxidative stress, and pulmonary hypertension through the NPR3/AKT/mTORC1 pathway.骨骼肌来源的肌肉素通过NPR3/AKT/mTORC1途径减轻糖酵解、氧化应激和肺动脉高压。
Acta Biochim Biophys Sin (Shanghai). 2024 Dec 5. doi: 10.3724/abbs.2024214.
8
Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension.线粒体作为肺动脉高压血管生成模式的主要决定因素。
J Exp Med. 2024 Nov 4;221(11). doi: 10.1084/jem.20231568. Epub 2024 Sep 25.
9
Early detection of pulmonary arterial hypertension through [F] positron emission tomography imaging with a vascular endothelial receptor small molecule.通过使用血管内皮受体小分子的[F]正电子发射断层扫描成像早期检测肺动脉高压。
Pulm Circ. 2024 Jul 26;14(3):e12393. doi: 10.1002/pul2.12393. eCollection 2024 Jul.
10
Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: A mini-review.EZH2介导的表观遗传修饰在心血管疾病血管平滑肌中的作用：一篇综述。
Front Pharmacol. 2024 Jun 27;15:1416992. doi: 10.3389/fphar.2024.1416992. eCollection 2024.
本文引用的文献
1
The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.抑制丙酮酸脱氢酶激酶可改善两种右心室肥厚模型中心功能和电重构障碍：使冬眠右心室复苏。
J Mol Med (Berl). 2010 Jan;88(1):47-60. doi: 10.1007/s00109-009-0524-6. Epub 2009 Dec 1.
2
Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.用于治疗肺动脉高压的5型磷酸二酯酶抑制剂。
N Engl J Med. 2009 Nov 5;361(19):1864-71. doi: 10.1056/NEJMct0904473.
3
Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.SM22α 靶向过表达 5-羟色胺转运体的小鼠应用二氯乙酸治疗部分逆转已建立的肺动脉高压。
FASEB J. 2009 Dec;23(12):4135-47. doi: 10.1096/fj.09-131664. Epub 2009 Aug 13.
4
Spotlight on sapropterin in primary hyperphenylalaninemia.原发性高苯丙氨酸血症中四氢生物蝶呤的聚焦
BioDrugs. 2009;23(3):201-2. doi: 10.2165/00063030-200923030-00007.
5
Updated clinical classification of pulmonary hypertension.肺动脉高压的更新临床分类。
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54. doi: 10.1016/j.jacc.2009.04.012.
6
Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.白细胞介素-6通过一条新的信号转导和转录激活因子3-微小RNA簇17/92途径调节Ⅱ型骨形态发生蛋白受体的表达。
Circ Res. 2009 May 22;104(10):1184-91. doi: 10.1161/CIRCRESAHA.109.197491. Epub 2009 Apr 23.
7
A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension.TRPC6基因启动子区一个与特发性肺动脉高压相关的功能性单核苷酸多态性。
Circulation. 2009 May 5;119(17):2313-22. doi: 10.1161/CIRCULATIONAHA.108.782458. Epub 2009 Apr 20.
8
Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension.利奥西呱（BAY 63-2521）的发现：一种用于治疗肺动脉高压的强效口服可溶性鸟苷酸环化酶刺激剂。
ChemMedChem. 2009 May;4(5):853-65. doi: 10.1002/cmdc.200900014.
9
Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells.血清素诱导肺动脉平滑肌细胞中Rho/ROCK依赖性的Smads 1/5/8激活。
FASEB J. 2009 Jul;23(7):2299-306. doi: 10.1096/fj.08-127910. Epub 2009 Feb 25.
10
Association of the metabolic syndrome with pulmonary venous hypertension.代谢综合征与肺静脉高压的关联。
Chest. 2009 Jul;136(1):31-36. doi: 10.1378/chest.08-2008. Epub 2009 Feb 2.
Zotero 插件